helicobacter pylori infection. Disease of stomach and duodenum, unspecified
Conditions
Interventions
Intervention 1: control group : 4 capsules containing pharmaceutical starch daily for 8 weeks in addition to conventional medical treatment of helicobacter pylori. Intervention 2: intervention group
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: positive result of helicobacter pylori infection
Exclusion criteria
Exclusion criteria: Body mass index greater than 30 Having an inflammatory or chronic diseases (kidney disease, liver disease, inflammatory bowel disease, heart ischemia, diabetes, lung disease, asthma, cancer, HIV, systemic inflammation and…) Having history of gastric cancer or gastric surgery Active GI bleeding and intense gastritis Taking any antibiotics or bismuth from 6 weeks before the study Taking all types of medication for helicobacter pylori before the study Pregnancy or lactation at the same time as studying Drinking alcohol or using narcotic at the same time as studying
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Appetite. Timepoint: at the beginning and the end of the study. Method of measurement: appetite questionnaire. | — |
Primary
| Measure | Time frame |
|---|---|
| Ghrelin hormone. Timepoint: at the beginning and the end of the study (after 8 weeks ). Method of measurement: ghrelin kit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHedie Yousefnejad
Shiraz University of Medical Sciences, Faculty of Nutrition and Food Sciences
Outcome results
None listed